1.
Zhonghua Nan Ke Xue
; 12(4): 358-61, 2006 Apr.
Artigo
em Chinês
| MEDLINE
| ID: mdl-16683575
RESUMO
With the development of the proteomics technology, more and more tumorous labeled substrates have been discovered and applied to clinical practice. This can provide the forepart diagnosis of tumor and prognosis monitoring with the reliable evidence. A summary is given of the study strategy of proteomics and its application in the prostatic carcinoma research.